Chinese english Germany Japanese Korea

Neu-2000

Neu-2000 Struktur
640290-67-1
CAS-Nr.
640290-67-1
Englisch Name:
Neu-2000
Synonyma:
Neu-2000;Nelonemdaz;Salfaprodil free base;Benzoic acid, 2-hydroxy-5-[[[2,3,5,6-tetrafluoro-4-(trifluoromethyl)phenyl]methyl]amino]-
CBNumber:
CB73145550
Summenformel:
C15H8F7NO3
Molgewicht:
383.22
MOL-Datei:
640290-67-1.mol
Request For Quotation

Neu-2000 Eigenschaften

Siedepunkt:
438.2±45.0 °C(Predicted)
Dichte
1.659±0.06 g/cm3(Predicted)
storage temp. 
Store at -20°C
Löslichkeit
DMSO : ≥ 112.5 mg/mL (293.57 mM)
pka
3.26±0.10(Predicted)

Sicherheit

Neu-2000 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Neu2000, is an uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist.

Neu-2000 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Neu-2000 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 19)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc. 		+1-781-999-5354 +1-00000000000
 marketing@targetmol.com United States 19892 58
Wuhan Topule Biopharmaceutical Co., Ltd 		+8618327326525
 masar@topule.com China 8474 58
Aladdin Scientific 		+1-833-552-7181
sales@aladdinsci.com United States 52927 58
Shanghai Boyle Chemical Co., Ltd.
sales@boylechem.com China 2923 55
Sichuan Wei Keqi Biological Technology Co., Ltd. 028-81700200 18116577057
 3003855609@qq.com China 7892 56
Shanghai Biopharmaleader Co., Ltd. +86 18721201413
sales@biopharmaleader.com China 1720 58
Guangzhou Belka Biological Technology Co., Ltd. +86-18665676617
 China 958 58
Wuhan Biocar Pharmacy Co.，Ltd 18665676617
 2956176220@qq.com China 61 58
Kaifeng Mingren Pharmaceutical Co.,LTD 0371-65741762
sales@hasunny.com China 2380 58
TargetMol Chemicals Inc. 4008200310
 marketing@tsbiochem.com China 24131 58
  • Neu-2000
  • Benzoic acid, 2-hydroxy-5-[[[2,3,5,6-tetrafluoro-4-(trifluoromethyl)phenyl]methyl]amino]-
  • Nelonemdaz
  • Salfaprodil free base
  • 640290-67-1
  • C15H8F7NO3
Copyright 2019 © ChemicalBook. All rights reserved